Introduction

Hemorrhagic stroke is a disastrous cerebrovascular accident with high morbidity and mortality1. Hemorrhagic stroke patients generally require critical care in intensive care unit (ICU), mechanical ventilation is the major risk factor for the death of hemorrhagic stroke patients, the mortality ranges from 40 to 80% in previous literatures2,3.

Scoring systems have been designed to predict prognosis for ages, some of scoring systems have been extensively used in ICU for critical illness, for example, the Simplified Acute Physiology Score II (SAPS II)4. SAPSII was developed to assess the severity of critically ill patients primordially, including hemorrhagic stroke patients in ICU. With the application of SAPSII, patients under threat of dying from hemorrhagic stroke patients was identified. The SAPSII contains complex laboratory results, while clinicians usually prefer a score system which is easy to perform without lots of laboratory parameters. The Oxford Acute Severity of Illness Score (OASIS) was raised by Johnson, Kramer & Clifford in 2013, it is a new critical illness score based on machine-learning algorithms with no laboratory parameter, which possessed comparable discrimination and standard than other complex scores5,6. In consideration of the predictive value of the OASIS was mainly evaluated among mixed critical ill patients, its predictive value in hemorrhagic stroke patients remains undiscovered. So we assessed the correlation between OASIS and the prognosis of hemorrhagic stroke patients in ICU, and compared its predictive value with the SAPS II.

Methods

Database and criteria

The MIMIC-III is a freely-available database, consists of clinical data of more than 40,000 patients who was hospitalized in the Beth Israel Deaconess Medical Center from 2001 to 20127. It contains detailed data including clinical outcomes, lab results, scoring systems and so on8. The data in MIMIC-III underwent de-identification, and the utilization of the database for research purposes was granted approval by the Institutional Review Boards of Massachusetts Institute of Technology and Beth Israel Deaconess Medical Center. As a result, the informed consent and approval of the Institutional Review Board were waived.

Inclusion criteria were: (1) patients were diagnosed as hemorrhagic stroke, namely either subarachnoid hemorrhage (SAH; ICD-9 430) or intracerebral hemorrhage (ICH; ICD-9 431)9; (2) patients were more than 18 years old; (3)Patients were admitted to ICU, if the same patient was admitted to ICU repeatedly, first admission was chosen. Exclusion criteria were: (1) patients who stayed ICU for less than 24 h; (2) clerical error, such as the ICU stay was longer than hospital stay. Because the patients are de-identified, no informed consent was required.

Data extraction

Transact-SQL and related MIMIC-III codes were applied to extract data10. General information including age, sex was extracted from the MIMIC-III database, so was the inspection result including white blood cell count, blood platelet and hemoglobin on admission. Data on hemorrhagic stroke severity score systems were also extracted including OASIS, SAPSII and Glasgow Coma Scale (GCS) on admission. For comorbidity evaluation, we extracted the Elixhauser score, chronic obstructive pulmonary disease, coronary heart disease, hypertension and diabetes. Length of ICU stay and hospital stay were computed according to the extracted data. Patients whose ages were more than 89 years old shifted to 300 years for privacy, before analyses we corrected them by this formula: age-300 + 89.

Outcomes

The primary research outcome was 30-day mortality, while ICU mortality and hospital mortality were considered as secondary outcomes. The length of ICU stay and hospital stay were excluded from the analysis, serving only for statistical description.

Statistical analysis

The descriptive statistics for continuous variables included the median, 25th percentile, and 75th percentile. Categorical variables were presented as frequencies and percentages. Mann-Whitney U tests were used to analyze continuous variables, while Chi-squared tests were employed for comparing categorical variables, if the values of categorical variables were below 10, Fisher’s exact tests were applied instead of Chi-squared tests. A multivariable logistic regression was performed for assessing the associations of OASIS and ICU outcomes. The determinants of the primary outcome were evaluated by univariable logistic analyses, the variables with p value<0.2 were applied for the multiple analyses. The AUC was used to comparing the discriminatory power between two score system, the statistical significance of the discriminative difference was tested with the DeLong test for correlated ROC curves. The most appropriate threshold of each scoring system was determined by Youden’s index, Kaplan–Meier curves was applied to assess the survival of patients grouped by threshold. we performed sensitive analyses by excluding patients more than 80 years old to test the stableness of the results. Different subgroups stratified by GCS score were analyses by logistic regression analyses to evaluate association between OASIS and the primary outcome. Software Stata V.11.2All was used to statistical analyses. All tests were two sided, the significance level was identified as p = 0.05.

Use of experimental animals, and human participants

The present study was a retrospective analysis utilizing openly accessible datasets and did not deal with human participants or cohorts. Consequently, the requirement for consent was inapplicable. Solely computational methodologies were employed, with no implementation of clinical or experimental approaches. All procedures adhered to pertinent guidelines and regulations.

Results

Baseline characteristics of patients

A total of 1838 hemorrhagic stroke patients in ICU were included in this analysis, comprising 1279 survivors and 559 non-survivors, the median of OASIS on admission is 33 (27–39). The median age of the patients was 66.57 years (54.08–78.56), 942 patients (52.64%) were male. The Comorbidities of chronic obstructive pulmonary disease, coronary heart disease, hypertension and diabetes were 0.54%, 10.34%, 58.43% and 19.04% respectively. The 30-day mortality was 30.41% (559 non-survivors and 1279 survivors). The hospital mortality and ICU mortality were 25.57% and 20.02% respectively. The length of ICU stay was 3.21(1.67–8.42), and the length of hospital stay was 8.67(4.5-15.58). More details are presented in Table 1.

Table 1 Characteristics and comparison between survivors and non-survivors determined by 30-day mortality.

OASIS and clinical outcomes of hemorrhagic stroke patients

The OASIS on admission of non-survivors was significantly higher than that of survivors (39 (34–44) vs. 30 (25–36), p < 0.001), the distributions of OASIS and SAPSII with relevant 30-day mortality were showed in Fig. 1. The 30-day mortality increased as OASIS increased to a first approximation, so was the 30-day mortality and SAPSII. The age, initial white blood cell count, initial platelet count, initial hemoglobin concentration, GCS and the Elixhauser Comorbidity Index were used in the multivariable regression analyses according to the univariable logistic regression analyses (presented in Table S5). By the adjusted multivariable regression analyses, the OASIS demonstrated a significant association with 30-day mortality (OR 1.125 per one-point increase, 95%CI [1.107–1.144], p < 0.0001), ICU mortality (OR 1.150 per one-point increase, 95% CI [1.128–1.172], p < 0.001), and hospital mortality (OR 1.140 per one-point increase, 95% CI [1.121–1.161], p < 0.001), more details were showed in Table 2. Results of analyses of the SAPS II are presented in Table S6.

Fig. 1
figure 1

Association between different severity scores on admission and 30-day mortality. (A) 30-day mortality by OASIS on admission among critical patients with hemorrhagic stroke; (B) 30-day mortality by SAPSII on admission among critical patients with hemorrhagic stroke. OASIS, Oxford Acute Severity of Illness Score; SAPSII, Simplified Acute Physiology Score II.

Table 2 Association of OASIS with 30-day mortality, ICU mortality and hospital mortality.

Discriminatory power of the OASIS in hemorrhagic stroke patients

The AUC of OASIS for predicting 30-day mortality was 0.7702 (95% CI [0.748–0.793]), which demonstrated comparable performance to the SAPSII score (AUC 0.788, 95% CI [0.766–0.810], P = 0.096) (Figure S3). The best threshold of OASIS was 35, the specificity and sensitivity were 72.45% and 69.43% respectively, positive likelihood ratio was 2.3699 and negative likelihood ratio was 0.3968 (Table S7). The AUC of OASIS for predicting ICU mortality and hospital mortality were similar to that of SAPSII, as presented in Figure S3. The Kaplan–Meier curves showed that higher OASIS score predicted shorter survival time for hemorrhagic stroke patients, so was the SAPSII (Figure S4).

We further evaluated the performance of the OASIS and SAPSII scales in predicting 30-day mortality in ICU patients(including hemorrhagic stroke and non-hemorrhagic stroke patients in ICU, in total 53423 patients), and found that SAPSII had a significantly higher AUC for predicting 30-day mortality rate compared to OASIS (AUC 0.793, 95%CI[0.787–0.798] vs. AUC 0.760, 95%CI[0.754–0.767], p = 0.000). This suggests that the predictive efficacy of the OASIS and SAPSII scales for prognosis differs between hemorrhagic stroke patients and ICU patients (Figure S5).

Sensitive analyses

We performed sensitive analyses to evaluate the stableness of results by excluded hemorrhagic stroke patients who are more than 80 years old (> 80 years old). The OASIS was still significantly correlated with 30-day mortality (OR = 1.125, 95% CI [1.103–1.146], p < 0.001), ICU mortality (OR = 1.156, 95% CI [1.131–1.182, p < 0.001), and hospital mortality (OR = 1.144, 95% CI [1.121–1.168, p < 0.001) by the multivariable regression analyses, the results were showed in Table S3. Association of SAPSII scores with outcomes were showed in Tables S8.

Subgroup analyses

The severity of hemorrhagic stroke patients was stratified by GCS, subgroup analysis was performed to evaluate the association of OASIS with 30-day mortality across different patients grouped by GCS. The results were showed in Table S4 and Fig. 2, indicated that the OASIS had similar discriminatory power to the SAPSII for predicting 30-day mortality and ICU mortality expect for predicting 30-day mortality of moderate hemorrhagic stroke patients (GCS 9–12 subgroup), OASIS had lower discriminatory abilities to predict 30-day mortality of GCS 9–12 subgroup than SAPSII (AUC 0.61 with 95% CI [0.53–0.69] vs. AUC 0.70 with 95% CI [0.63–0.78], P = 0.019).

Fig. 2
figure 2

Comparison the discriminatory ability of OASIS and SAPSII on admission for predicting 30-day mortality and ICU mortality stratified by GCS. (A) Comparing AUCs for 30-day mortality by OASIS and SAPSII stratified by GCS; (B) Comparing AUCs for ICU mortality by OASIS and SAPSII stratified by GCS. OASIS, the Oxford Acute Severity of Illness Score; ICU, intensive care unit; SAPS II, Simplified Acute Physiology Score II; AUC, area under the ROC curve; ROC, receiver operating characteristic.

Discussion

In this study, we retrospected 1838 hemorrhagic stroke patients from MIMIC-III database and revealed that OASIS on admission was significantly correlated with the prognosis of hemorrhagic stroke patients, the 30-day mortality, ICU mortality and hospital mortality increased as the OASIS of patients increased. When comparing to SAPSII, we found that OASIS had the comparable discriminatory power to predict ICU mortality for hemorrhagic stroke patients, OASIS also had the comparable discriminatory power to predict 30-day mortality for the severe (GCS 3–8) and mild (13–15) hemorrhagic stroke patients, but it had lower discriminatory power to predict 30-day mortality for the moderate (9–12) patients, which might be attributed to that OASIS relied on gross physiological derangements with limits discriminative power in moderate patients. In contrast, SAPSII’s multi-organ profiling captures incipient metabolic disturbances (e.g., hypokalemia, respiratory alkalosis), enabling finer risk stratification within this heterogeneous subgroup. For all we know, this was the first time to evaluate the prediction value of OASIS for critical hemorrhagic stroke patients, so was the first time to comparing the discriminatory power between OASIS and SAPSII for predicting the prognosis of hemorrhagic stroke patients.

There are several scoring systems used in ICU that designed to predict the prognosis of critical patients11. Patients in ICU consist of different spectrums of critical disease, conflicting conclusions have been reported when evaluating the predictability of various scoring systems12,13, indicates that appropriate scoring system should be chosen for specific critical disease. SAPSII is usually applied to predict the prognosis of critical patients in ICU, which includes 17 types of clinical data about physiological data, main organ systems and other parameters14. OASIS is a new critical illness score designed in 2013, which comprising 10 convenient parameters including age, length of hospital stay prior ICU admission, heart rate, mean arterial pressure, respiratory rate, core body temperature, Glasgow Coma Scale, urine volume, respiratory support and datechosen operation5. OASIS is more easy-to-use than SAPSII in daily assessment for ICU patients on account of simple components which contains few laboratory results. Previous studies found that SAPSII had higher discriminatory abilities than OASIS for predicting the mortality of sepsis patients6, but the predictive value of OASIS for the prognosis of hemorrhagic stroke patients, and which scoring system is the better choice, still remains unknown. Our study may provide some help for clinicians to make decision, OASIS was significantly correlated with clinical outcomes of hemorrhagic stroke patients, and OASIS may be a better choice than SAPSII when evaluating the prognosis of severe and mild patients because of its’ convenience. To evaluate the stability, we performed sensitive analyses by excluding the patients who were more than 80 years old. Our conclusions were stability because the results of sensitive analyses were consistent.

There were some limitations for this study. First, selection bias was unavoidable because this study was a retrospective observational study. Second, we did not take several variables into consideration because the missing data was large, such as body mass index. Third, the performance of the OASIS might be overestimated because we ignored that the data in the study was from different ICUs. Fourth, this study included a total of 1,838 patients, which is considered a relatively small sample size. Therefore, future multicenter studies with larger-scale cohorts are required to validate the conclusions.

Conclusion

In conclusion, the admission OASIS was found to have a significant association with the short-term outcomes of patients with hemorrhagic stroke, it had comparable discriminatory power for prognosis prediction of severe and mild patients and had lower discriminatory power for prognosis prediction of moderate patients, which suggesting that the OASIS might serve as an alternative choice to predict outcomes of severe and mild hemorrhagic stroke patients considering the practicability.